$BCRX 2022 Biotech on watch....

BioCryst Pharmaceuticals, Inc.NASDAQ

Description

⋅ Jan 3, 2022 5:02 PM

Been watching this for years, great pipeline, nice set up to start the year. First target is $15's if we break through here, then ATH's and blue skies.